Experimental Heart Drug Helps Patients Exercise More and Feel Better

An experimental drug, aficamten, has shown promising results in improving exercise capacity and reported health in patients with nonobstructive hypertrophic cardiomyopathy (nHCM), an inherited heart condition.

Two new studies found that the drug helped patients with nHCM feel better and exercise more, potentially offering a new treatment option for this condition.